Immune checkpoint inhibitor-related adverse cardiac events in patients with lung cancer: a systematic review and meta-analysis.

Cancer Cell Int · 2022 · PMC9675058 · PMID 36402980

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Secondary outcomes The incidences of any cardiac AEs with single ICI, single ICI plus chemotherapy, and dual ICI plus or minus radiotherapy were 0.007 [95% CI 0.001–0.015], 0.019 [95% CI 0–0.048], and 0.024 [95% CI 0–0.068], respectively, showing that they were in an increasing trend.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.